287 related articles for article (PubMed ID: 10360653)
1. Boswellic acids and malignant glioma: induction of apoptosis but no modulation of drug sensitivity.
Glaser T; Winter S; Groscurth P; Safayhi H; Sailer ER; Ammon HP; Schabet M; Weller M
Br J Cancer; 1999 May; 80(5-6):756-65. PubMed ID: 10360653
[TBL] [Abstract][Full Text] [Related]
2. Potentiation of CD95L-induced apoptosis of human malignant glioma cells by topotecan involves inhibition of RNA synthesis but not changes in CD95 or CD95L protein expression.
Winter S; Weller M
J Pharmacol Exp Ther; 1998 Sep; 286(3):1374-82. PubMed ID: 9732400
[TBL] [Abstract][Full Text] [Related]
3. Dexamethasone-mediated protection from drug cytotoxicity: association with p21WAF1/CIP1 protein accumulation?
Naumann U; Durka S; Weller M
Oncogene; 1998 Sep; 17(12):1567-75. PubMed ID: 9794234
[TBL] [Abstract][Full Text] [Related]
4. The topoisomerase II inhibitor, genistein, induces G2/M arrest and apoptosis in human malignant glioma cell lines.
Schmidt F; Knobbe CB; Frank B; Wolburg H; Weller M
Oncol Rep; 2008 Apr; 19(4):1061-6. PubMed ID: 18357397
[TBL] [Abstract][Full Text] [Related]
5. Identification of p21 as a target of cycloheximide-mediated facilitation of CD95-mediated apoptosis in human malignant glioma cells.
Glaser T; Wagenknecht B; Weller M
Oncogene; 2001 Aug; 20(35):4757-67. PubMed ID: 11521188
[TBL] [Abstract][Full Text] [Related]
6. CCNU-dependent potentiation of TRAIL/Apo2L-induced apoptosis in human glioma cells is p53-independent but may involve enhanced cytochrome c release.
Röhn TA; Wagenknecht B; Roth W; Naumann U; Gulbins E; Krammer PH; Walczak H; Weller M
Oncogene; 2001 Jul; 20(31):4128-37. PubMed ID: 11464279
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-1 beta-converting enzyme mediates cisplatin-induced apoptosis in malignant glioma cells.
Kondo S; Barna BP; Morimura T; Takeuchi J; Yuan J; Akbasak A; Barnett GH
Cancer Res; 1995 Dec; 55(24):6166-71. PubMed ID: 8521409
[TBL] [Abstract][Full Text] [Related]
8. Crm-A, bcl-2 and NDGA inhibit CD95L-induced apoptosis of malignant glioma cells at the level of caspase 8 processing.
Wagenknecht B; Schulz JB; Gulbins E; Weller M
Cell Death Differ; 1998 Oct; 5(10):894-900. PubMed ID: 10203695
[TBL] [Abstract][Full Text] [Related]
9. Low concentrations of paclitaxel induce cell type-dependent p53, p21 and G1/G2 arrest instead of mitotic arrest: molecular determinants of paclitaxel-induced cytotoxicity.
Giannakakou P; Robey R; Fojo T; Blagosklonny MV
Oncogene; 2001 Jun; 20(29):3806-13. PubMed ID: 11439344
[TBL] [Abstract][Full Text] [Related]
10. Human autoreactive and foreign antigen-specific T cells resist apoptosis induced by soluble recombinant CD95 ligand.
Zipp F; Martin R; Lichtenfels R; Roth W; Dichgans J; Krammer PH; Weller M
J Immunol; 1997 Sep; 159(5):2108-15. PubMed ID: 9278296
[TBL] [Abstract][Full Text] [Related]
11. NF-kappaB-independent actions of sulfasalazine dissociate the CD95L- and Apo2L/TRAIL-dependent death signaling pathways in human malignant glioma cells.
Hermisson M; Weller M
Cell Death Differ; 2003 Sep; 10(9):1078-89. PubMed ID: 12934082
[TBL] [Abstract][Full Text] [Related]
12. Death ligand/receptor-independent caspase activation mediates drug-induced cytotoxic cell death in human malignant glioma cells.
Glaser T; Wagenknecht B; Groscurth P; Krammer PH; Weller M
Oncogene; 1999 Sep; 18(36):5044-53. PubMed ID: 10490841
[TBL] [Abstract][Full Text] [Related]
13. Sensitization of tumor cells to Apo2 ligand/TRAIL-induced apoptosis by inhibition of casein kinase II.
Ravi R; Bedi A
Cancer Res; 2002 Aug; 62(15):4180-5. PubMed ID: 12154014
[TBL] [Abstract][Full Text] [Related]
14. The proliferative inhibition and apoptotic mechanism of Saikosaponin D in human non-small cell lung cancer A549 cells.
Hsu YL; Kuo PL; Lin CC
Life Sci; 2004 Jul; 75(10):1231-42. PubMed ID: 15219811
[TBL] [Abstract][Full Text] [Related]
15. Influence of Bax or Bcl-2 overexpression on the ceramide-dependent apoptotic pathway in glioma cells.
Sawada M; Nakashima S; Banno Y; Yamakawa H; Takenaka K; Shinoda J; Nishimura Y; Sakai N; Nozawa Y
Oncogene; 2000 Jul; 19(31):3508-20. PubMed ID: 10918609
[TBL] [Abstract][Full Text] [Related]
16. Time-dependent changes in factors involved in the apoptotic process in human ovarian cancer cells as a response to cisplatin.
Kolfschoten GM; Hulscher TM; Schrier SM; van Houten VM; Pinedo HM; Boven E
Gynecol Oncol; 2002 Mar; 84(3):404-12. PubMed ID: 11855878
[TBL] [Abstract][Full Text] [Related]
17. Adenovirus-mediated expression of p53 or p21 in a papillary serous endometrial carcinoma cell line (SPEC-2) results in both growth inhibition and apoptotic cell death: potential application of gene therapy to endometrial cancer.
Ramondetta L; Mills GB; Burke TW; Wolf JK
Clin Cancer Res; 2000 Jan; 6(1):278-84. PubMed ID: 10656459
[TBL] [Abstract][Full Text] [Related]
18. p21 promotes ceramide-induced apoptosis and antagonizes the antideath effect of Bcl-2 in human hepatocarcinoma cells.
Kang KH; Kim WH; Choi KH
Exp Cell Res; 1999 Dec; 253(2):403-12. PubMed ID: 10585263
[TBL] [Abstract][Full Text] [Related]
19. Cytoprotective effects of hematopoietic growth factors on primary human acute myeloid leukemias are not mediated through changes in BCL-2, bax, or p21WAF1/CIP1.
DiGiuseppe JA; Kastan MB; Weng LJ; Gore SD
In Vivo; 1999; 13(1):1-6. PubMed ID: 10218124
[TBL] [Abstract][Full Text] [Related]
20. Topoisomerase-I inhibitors for human malignant glioma: differential modulation of p53, p21, bax and bcl-2 expression and of CD95-mediated apoptosis by camptothecin and beta-lapachone.
Weller M; Winter S; Schmidt C; Esser P; Fontana A; Dichgans J; Groscurth P
Int J Cancer; 1997 Nov; 73(5):707-14. PubMed ID: 9398050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
